Western medicine is officially forbidden to prescribe Chinese patent medicine

[pharmaceutical network industry news] recently, Guangdong People's hospital issued a notice entitled "letter to patients' friends" The letter to patients made it clear that non TCM doctors were prohibited from prescribing herbal pieces and proprietary Chinese medicines As early as August 21, Zeng issued a document by Guangdong health and Health Commission, which made it clear that the use of Chinese herbal pieces and proprietary Chinese medicines should be standardized The notice issued by the people's Hospital of Guangdong Province can also be regarded as another implementation of the national policy of Guangdong Province It is understood that the people's Hospital of Guangdong Province has 12 national key clinical specialties and 34 key clinical medicine specialties / disciplines in Guangdong Province It is a large-scale comprehensive hospital in Guangdong Province, one of the large-scale hospitals with strong comprehensive strength in China, and its outpatient and emergency volume is also among the top in the country If Western medicine can't prescribe Chinese patent medicine in such a large hospital, it will be a huge blow and test for many traditional Chinese medicine enterprises, especially for the agents of Chinese patent medicine products In fact, on July 1, 2019, the national health and Health Commission issued the notice on printing and distributing a batch of national key monitoring and rational drug catalog (chemical medicine and biological products), which clearly stipulated that non TCM doctors need to go through at least one year of TCM training before they can prescribe Chinese patent medicine, which caused an uproar in the industry If it is implemented, most doctors in the country will not be able to prescribe proprietary Chinese medicine In addition, many people are worried about reducing the use of proprietary Chinese medicine in clinical practice On the one hand, this will affect the development of traditional Chinese medicine, on the other hand, it will also reduce the sales of proprietary Chinese medicine, causing serious impact on the enterprises of proprietary Chinese medicine But the key turning point was in late August It is understood that on August 30, in the national teleconference to promote the rational drug use management of medical institutions, director Zhang Zongjiu of the medical administration bureau of the national health and Health Commission also made a new interpretation of the policy of Western doctors' prescription of traditional Chinese medicine: encourage Western doctors to learn the theory of traditional Chinese medicine, follow the characteristics and laws of traditional Chinese medicine and the principles and norms of dialectical treatment, and use traditional Chinese medicine reasonably, rather than forbidding or restricting Western medicine prescribes Chinese patent medicine The fundamental purpose of the policy is to improve the clinical application level of traditional Chinese medicine and promote the sustainable and healthy development of traditional Chinese medicine It is mainly used for the performance appraisal of the third level public hospitals, and the focus of implementation is the third level public hospitals For county-level (second level) hospitals, no rigid requirements will be made temporarily, which will be gradually implemented in the next step of county-level (second level) hospital performance evaluation For 250000 general practitioners and 900000 rural doctors in primary medical institutions, it is clear that they can prescribe common and frequently occurring traditional Chinese medicine, or continue to use the long-term prescription of traditional Chinese Medicine issued by traditional Chinese medicine practitioners With the new interpretation of national policy, there have been many responses For example, on September 4, Shandong issued a document As for the problem of "prescription restriction" of Chinese patent medicine, Shandong only assessed the third level hospitals, while the county-level (second level) hospitals did not make any rigid requirements temporarily This means that there is still no prescription obstacle for Chinese patent medicine in Shandong county-level hospitals This is also the first provincial health and Health Commission to clarify the prescription authority of Chinese patent medicine after the publication of the national key monitoring and rational drug use catalogue
On September 9, Guizhou health and Health Commission printed and distributed the list of national key monitoring drugs for rational use in Guizhou Province At the same time, in the aspect of standardizing the issuance of Chinese patent medicines by Western doctors, two points were made clear: at present, the issuance of Chinese patent medicines by Western doctors is mainly used for the performance evaluation of level 3 public hospitals, and there is no requirement for county (Level 2) hospitals, which will be gradually implemented in the next level 2 hospital performance evaluation work Shi For general practitioners and rural doctors in grass-roots medical institutions, they can prescribe commonly used Chinese patent medicines for common and frequently occurring diseases, or continue to use the long-term prescriptions of Chinese patent medicines issued by Chinese doctors On September 12, Hainan issued a batch of key monitoring catalogues At the same time, the notice pointed out that those who have obtained the qualification of doctors outside the category of traditional Chinese medicine and registered in the third level hospital, and have received the course of traditional Chinese medicine in college education and post graduation education can issue the prescription of traditional Chinese medicine General practitioners and rural doctors in primary medical institutions can prescribe commonly used Chinese patent medicines for common and frequently occurring diseases, or continue to use long-term prescriptions of Chinese patent medicines issued by traditional Chinese medicine practitioners On the same day, Shaanxi Provincial Health and Health Commission issued a document to clarify that doctors in primary medical institutions can issue prescriptions for Chinese patent medicines, but there was no clear arrangement for western medicine in grade hospitals Subsequently, Inner Mongolia also issued a notice on doing a good job in the region's key monitoring of rational drug use management The notice shows that the western medicine of the hospitals above the second level can continue to be issued by the doctors who have been in clinical posts and provided the corresponding Chinese medicine prescription services, which means that the western medicine of the hospitals above the second level who have previously issued the Chinese patent medicine prescription can probably issue the Chinese patent medicine prescription From the current implementation of prescription restriction of Chinese patent medicine in many places, most cities are relaxing the restrictions of Western medicine doctors on prescription of traditional Chinese medicine, so that the channels of Chinese patent medicine sink It seems that the primary and secondary medical institutions are the main battlefield of traditional Chinese medicine in the future However, some insiders pointed out that with the release of national policies and the further promotion of medical reform measures in the future, China's traditional Chinese medicine market will face tremendous pressure of transformation and upgrading In the future, clinical efficacy may become the core index of traditional Chinese medicine in clinical use.